QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-genesco-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.

 stocks-that-hit-52-week-lows-on-thursday

  During Thursday, 56 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-wednesday

  Wednesday saw 59 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 56 companies set new 52-week lows.

 cyclerion-regains-compliance-with-nasdaq-minimum-bid-price-requirement

Cyclerion's stock will continue to be listed and traded on the Nasdaq Capital Market.

 why-rh-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture r...

 cyclerion-therapeutics-to-sell-assets-for-81m-ceo-transition-to-new-spin-off-private-company-established-by-shareholders-new-investors

Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (formerly CY6463) and CY3018, to a ...

 cyclerion-therapeutics-reports-q1-net-loss-of-70m-vs-130m-last-year

Net loss was approximately $(7.0) million for Q1 2023, as compared to approximately $(13.0) million for Q1 2022.

 cyclerion-inks-definitive-agreement-for-zagociguat-and-cy3018

Certain Cyclerion shareholders and new investors have agreed to invest $81M to launch a new company targeting diseases of mitoc...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 220 stocks hit new 52-week lows.

 cyclerion-therapeutics-says-board-has-reviewed-non-binding-proposal-from-entity-formed-by-investors-including-cos-ceo-to-purchase-zagociguat-and-cy3018-assets-says-board-has-concluded-proposal-merits-further-pursuit

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) today announced that the Board of Directors of the Company, acting solely by all of ...

 why-jounce-therapeutics-shares-are-trading-higher-by-23-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION